Search results for "Cost-benefit analysi"

showing 10 items of 148 documents

Economic and environmental sustainability of submerged anaerobic MBR-based (AnMBR-based) technology as compared to aerobic-based technologies for mod…

2015

[EN] The objective of this study was to assess the economic and environmental sustainability of submerged anaerobic membrane bioreactors (AnMBRs) in comparison with aerobic-based technologies for moderate-/high-loaded urban wastewater (UWW) treatment. To this aim, a combined approach of steady-state performance modelling, life cycle analysis (LCA) and life cycle costing (LCC) was used, in which AnMBR (coupled with an aerobic-based post-treatment) was compared to aerobic membrane bioreactor (AeMBR) and conventional activated sludge (CAS). AnMBR with CAS-based post-treatment for nutrient removal was identified as a sustainable option for moderate-/high-loaded UWW treatment: low energy consump…

INGENIERIA HIDRAULICAEngineeringEnvironmental EngineeringCost-Benefit Analysis0208 environmental biotechnologySewageEnvironmental pollution02 engineering and technologyWastewater010501 environmental sciencesManagement Monitoring Policy and LawMembrane bioreactorGlobal Warming01 natural sciencesWater PurificationBioreactorsBioreactorAnaerobiosisWaste Management and DisposalTECNOLOGIA DEL MEDIO AMBIENTE0105 earth and related environmental sciencesLife cycle costing (LCC)SewageLife cycle analysis (LCA)Steadystate performance modellingbusiness.industryUrbanizationSubmerged anaerobic MBR (AnMBR)Environmental engineeringMembranes ArtificialGeneral MedicineModels TheoreticalGlobal warming potential (GWP)Aerobiosis020801 environmental engineeringActivated sludgeWastewaterSewage treatmentEnvironmental PollutionbusinessAnaerobic exerciseJournal of Environmental Management
researchProduct

New development opportunities for the craft brewing segment: the case study of a micro-malthouse

2017

In Italy in the past few years, the number of small breweries penetrating the craft beer sector has grown exponentially. Craft producers intend to give a strong added value and a local character to their production in different ways. One of these is the use of malt derived from small batches of local cereals and pseudo cereals. The aim of this study is the assessment of investment profitability, through a cost-benefit analysis (CBA), for a compact and a modular micro-malting plant in Sicily (Southern Italy). The CBA for a micro-malthouse was carried out considering both installation and operating costs. Net present value (NPV), discounted benefit-cost ratio (DBCR) and internal rate of retur…

Internal areasInformation Systems and Managementinternal areas.Management Science and Operations ResearchNet present valueCBA; Cereal processing; Cost-benefit analysis; Internal areas; Malting; Malting plant; SicilyCraftAgricultural scienceSettore AGR/01 - Economia Ed Estimo RuraleAdded valueProduction (economics)maltingBusiness and International ManagementSicilybusiness.industryCost-benefit analysisInternal rate of returnSettore AGR/15 - Scienze E Tecnologie AlimentariInvestment (macroeconomics)malting plantcereal processingcost–benefit analysiBrewingProfitability indexbusinessCBA
researchProduct

Coauthorship and institutional collaborations on cost-effectiveness analyses: a systematic network analysis

2012

BackgroundCost-Effectiveness Analysis (CEA) has been promoted as an important research methodology for determining the efficiency of healthcare technology and guiding medical decision-making. Our aim was to characterize the collaborative patterns of CEA conducted over the past two decades in Spain.Methods and findingsA systematic analysis was carried out with the information obtained through an updated comprehensive literature review and from reports of health technology assessment agencies. We identified CEAs with outcomes expressed as a time-based summary measure of population health (e.g. quality-adjusted life-years or disability-adjusted life-years), conducted in Spain and published bet…

Knowledge managementNon-Clinical MedicineCost effectivenessScience PolicyEconomicsPolitical ScienceCost-Benefit AnalysisSciencePublic PolicyBibliometricsTechnology assessmentSocial and Behavioral SciencesInvestigacióHealth EconomicsSociologyMedicineCooperative BehaviorHealth Systems StrengtheningMultidisciplinaryHealth economicsHealth Care PolicyCost–benefit analysisbusiness.industryQHealth services researchRHealth technologyCost-effectiveness analysisResearch AssessmentAuthorshipSocial NetworksBibliometricsMedicinebusinessResearch Article
researchProduct

Efficacy and cost-effectiveness of the UltraCision harmonic scalpel in thyroid surgery: an analysis of 200 cases in a randomized trial.

2004

Thyroid surgery technique has undergone very few changes in the last century. The UltraCision harmonic scalpel (UHS) (Smithfield, RI) has been widely used in laparoscopic surgery and is documented to be safe and fast for cutting and coagulating tissue. We studied whether the use of the UHS could have advantages in thyroid surgery in terms of operative time, length of hospitalization, morbidity, and general costs.Our study was a prospective randomized trial of thyroidectomies and lobectomies performed for benign thyroid diseases in an endocrine surgery unit between February 2001 and July 2002. Patients were randomized in two groups: group A (n=100) underwent thyroidectomy using UHS and group…

Laparoscopic surgeryAdultMalemedicine.medical_specialtyAdolescentCost effectivenessmedicine.medical_treatmentCost-Benefit Analysislaw.inventionRandomized controlled triallawmedicineHarmonic scalpelHumansProspective StudiesProspective cohort studyAgedUltrasonographyAged 80 and overbusiness.industryThyroidectomyMiddle AgedThyroid DiseasesSurgeryClinical trialEndocrine surgeryTreatment OutcomeThyroidectomySurgeryFemalebusinessJournal of laparoendoscopicadvanced surgical techniques. Part A
researchProduct

The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017 : a systematic analysis for the Global Bu…

2020

Background\ud \ud Cirrhosis and other chronic liver diseases (collectively referred to as cirrhosis in this paper) are a major cause of morbidity and mortality globally, although the burden and underlying causes differ across locations and demographic groups. We report on results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 on the burden of cirrhosis and its trends since 1990, by cause, sex, and age, for 195 countries and territories.\ud \ud \ud \ud Methods\ud \ud We used data from vital registrations, vital registration samples, and verbal autopsies to estimate mortality. We modelled prevalence of total, compensated, and decompensated cirrhosis on the bas…

Liver CirrhosisMaleCirrhosisCost-Benefit AnalysisHEPATITIS-BGlobal Burden of DiseaseLiver diseaseDisability Evaluation0302 clinical medicineBurden Global Mortality CirrhosisNon-alcoholic Fatty Liver DiseaseRisk FactorsFIBROSISEurope EasternPOPULATIONAged 80 and overeducation.field_of_studySingaporeMortality rate1. No povertyGastroenterologyHepatitis CHepatitis BMiddle AgedHepatitis BHepatitis C3. Good healthPREVALENCE030220 oncology & carcinogenesisAsia Central030211 gastroenterology & hepatologyEgyptFemaleQuality-Adjusted Life YearsViral hepatitisLife Sciences & BiomedicineAdultEUROPEPopulationGBD 2017 Cirrhosis CollaboratorsArticle03 medical and health sciencesLIVER-DISEASEmedicineHumanseducationLiver Diseases AlcoholicAfrica South of the SaharaAgedScience & TechnologyHepatologyGastroenterology & Hepatologybusiness.industryMORTALITYDISABILITYDECOMPENSATIONmedicine.diseaseYears of potential life lostEarly DiagnosisSocioeconomic Factors3121 General medicine internal medicine and other clinical medicineINJURIESHuman medicinebusinessDemographyRCLancet gastroenterology & hepatology
researchProduct

Early Treatment in HCV: Is it a Cost-Utility Option from the Italian Perspective?

2016

In Italy, the Italian Pharmaceutical Agency (AIFA) criteria used F3–F4 fibrosis stages as the threshold to prioritise the treatment with interferon (IFN)-free regimens, while in genotype 1 chronic hepatitis C (G1 CHC) patients with fibrosis of liver stage 2, an approach with pegylated interferon (PEG-IFN)-based triple therapy with simeprevir was suggested. The key clinical question is whether, in an era of financial constraints, the application of a universal IFN-free strategy in naive G1 CHC patients is feasible within a short time horizon. The aim of this study is to perform an economic analysis to estimate the cost-utility of the early innovative therapy in Italy for managing hepatitis C…

Liver CirrhosisSimeprevirmedicine.medical_specialtyCost-Benefit AnalysisPopulationAntiviral Agents03 medical and health sciencesIndirect costs0302 clinical medicineAntiviral Agents; Cost-Benefit Analysis; Disease Progression; Hepatitis C Chronic; Humans; Interferons; Italy; Liver Cirrhosis; Markov Chains; Monte Carlo Method; Quality-Adjusted Life Years; Ribavirin; Simeprevir; Treatment Outcome; Pharmacology (medical)SimeprevirRibavirinmedicineHumansPharmacology (medical)030212 general & internal medicineChronicIntensive care medicineeducationReimbursementeducation.field_of_studyCost–benefit analysisbusiness.industryHealth services researchGeneral MedicineHepatitis CHepatitis C Chronicmedicine.diseaseHepatitis CMarkov ChainsQuality-adjusted life yearTreatment OutcomeItalyDisease Progression030211 gastroenterology & hepatologyInterferonsQuality-Adjusted Life YearsbusinessMonte Carlo MethodClinical Drug Investigation
researchProduct

Why do I treat my patients with mild hepatitis C?

2015

The major advances achieved in the treatment of HCV by the development of new direct-acting antiviral agents (DAAs) allow treatment of almost the entire spectrum of patients with chornic infection. As a result of the exceedingly high cost of DAAs in many countries, IFN-free DAA regimens are mostly reserved to patients with advanced fibrosis or cirrhosis. Hence, treatment of patients with milder liver disease is often deferred. This could ultimately result in an increased burden of advanced liver disease and in increased long-term costs of management. Moreover, studies performed during the 'interferon era' and the early data on interferon-free regimens show that patients without severe fibro…

Liver Cirrhosismedicine.medical_specialtyCirrhosisGenotypeCost-Benefit AnalysisHepacivirusDiseaseAntiviral AgentsGastroenterologyVirological response03 medical and health sciencesLiver disease0302 clinical medicineInternal medicineRibavirinHumansMedicine030212 general & internal medicineStage (cooking)Adverse effectHepatologybusiness.industryHcv clearanceInterferon-alphaHepatitis CHepatitis C Chronicmedicine.diseaseTreatment OutcomeImmunologyHCVDisease ProgressionDrug Therapy Combination030211 gastroenterology & hepatologybusiness
researchProduct

Impacto Clínico e Custo-Efetividade da FFR em Comparação à Angiografia em Pacientes com Doenças Multiarteriais Submetidos à ICP

2018

Abstract Background: In multivessel disease patients with moderate stenosis, fractional flow reserve (FFR) allows the analysis of the lesions and guides treatment, and could contribute to the cost-effectiveness (CE) of non-pharmacological stents (NPS). Objectives: To evaluate CE and clinical impact of FFR-guided versus angiography-guided angioplasty (ANGIO) in multivessel patients using NPS. Methods: Multivessel disease patients were prospectively randomized to FFR or ANGIO groups during a 5 year-period and followed for < 12 months. Outcomes measures were major adverse cardiac events (MACE), restenosis and CE. Results: We studied 69 patients, 47 (68.1%) men, aged 62.0 ± 9.0 years, 34 (49.2%…

MaleAcute coronary syndromemedicine.medical_specialtylcsh:Diseases of the circulatory (Cardiovascular) systemTime Factorsmedicine.medical_treatmentCost-Benefit AnalysisKaplan-Meier EstimateFractional flow reserveCoronary AngiographyRevascularizationStatistics NonparametricCoronary RestenosisAnginaAnálise de Custo BenefícioRestenosisDoença da Artéria CoronarianaInternal medicineAngioplastymedicineHumansAngina StableProspective Studiescardiovascular diseasesAcute Coronary SyndromeAngioplasty Balloon CoronaryAngioplastia Coronária com BalãoAgedmedicine.diagnostic_testbusiness.industryReserva Fracionada do Fluxo MiocárdioMiddle Agedmedicine.diseaseFractional Flow Reserve MyocardialTreatment Outcomelcsh:RC666-701AngiographyCardiologyFemaleStentsCardiology and Cardiovascular MedicinebusinessCoronary Artery Disease/economicsMaceArquivos Brasileiros de Cardiologia
researchProduct

Square-stepping exercise versus strength and balance training for fall risk factors

2008

Background and aims: Feasible and low-cost exercise programmes targeting fall risk factors may decrease the risk of falling in older adults. The purpose of this study was to compare the effects of square-stepping exercise (SSE) training, which is a new and low-cost method designed to improve lower-extremity functional fitness, with strength and balance (SB) training. Methods: The study included 39 community-dwelling adults aged 65 to 74 years. The participants were randomized to either group SSE (n=20) or SB (n=19). They engaged in 70-min group exercise sessions twice a week for 12 weeks. The efficacy of the program was measured with both a 9-item test battery for assessment of physical per…

MaleAgingmedicine.medical_specialtyFunctional trainingCost-Benefit AnalysisPhysical fitnessPoison controlHealth PromotionFear of fallinglaw.inventionPhysical medicine and rehabilitationRandomized controlled trialRisk FactorslawOutcome Assessment Health CaremedicineHumansMuscle StrengthExercise physiologyExercisePostural BalanceAgedBalance (ability)business.industryIncidenceIncidence (epidemiology)Physical therapyPatient ComplianceAccidental FallsFemaleGeriatrics and Gerontologymedicine.symptombusinessFollow-Up StudiesAging Clinical and Experimental Research
researchProduct

In-home versus hospital preoperative balance and proprioceptive training in patients undergoing TKR; rationale, design, and method of a randomized co…

2017

Abstract Background Severe knee osteoarthritis, as well as the surgical procedure of total knee replacement that aims to reduce its symptoms, cause great deterioration on the proprioceptive system. Taking this fact into account, and considering that balance abilities positively influence the capacity to perform basic functional tasks, this trial aims to find the short and mid-term effects of a preoperative balance and proprioceptive training when conducted by patients undergoing total knee replacement. Along with the effects, it is intended to determine whether in-home based training can be as effective as hospital training. The results will help to conclude whether the possible benefits ma…

MaleBalancemedicine.medical_specialtylcsh:Diseases of the musculoskeletal systemSports medicinemedicine.medical_treatmentCost-Benefit AnalysisPsychological interventionlaw.invention03 medical and health sciencesStudy Protocol0302 clinical medicineRheumatologyRandomized controlled trialQuality of lifelawPreoperative CaremedicineHumansOrthopedics and Sports Medicine030212 general & internal medicineDynamic balanceArthroplasty Replacement KneePostural BalancePhysiotherapyBalance (ability)AgedAged 80 and overRehabilitationbusiness.industryRecovery of FunctionMiddle AgedOsteoarthritis KneeProprioceptionHome Care ServicesHospitalizationTotal knee replacementSensorimotorTotal knee arthroplastyBerg Balance ScalePhysical therapyFemalelcsh:RC925-935Preoperative interventionbusiness030217 neurology & neurosurgeryPhysical Conditioning HumanBMC musculoskeletal disorders
researchProduct